References
- BANGHAm, A. D., 1981, Introduction. In Liposomes from Physical Structure to Therapeutic Applications, edited by C. G. Knight (Elsevier/North Holland Biomedical Press), pp. 1–7.
- BommEL, E. M. G. V., and CROMMELIN, D. J. A., 1984, Stability of doxorubicin liposomes on storage: As an aqueous dispersion, frozen or freeze-dried. International Journal of Pharmacology, 22, 299–310.
- ByuNG-NAK, A., SHIN- KEUN, K., and CHANG- Koo, S., 1995, Preparation and evaluation of proliposomes containing propranolol hydrochloride. Journal of Microencapsulation, 12, 363–375.
- GANAPAT, R., KRISHAN, A., WODINSKEY, I., ZUDROD, C. G., and LEsKE, L. J., 1980, Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 143-u-arabinofuranosylcytosine in vivo. Cancer Research, 40, 630–633.
- KAT ARE, 0. P., VYAS, S. P., and DIX IT, V. K., 1991, Preparation and performance evaluation of plain proliposomes systems for cytoprotectiort Journal of Microencapsulation, 8, 295–300.
- MEzEI, M., and NuGENT, F. J., 1984, Method of encapsulating biologically active materials in multilamellar lipid vesicles. US Patent 4,485,054.
- PAYNE, N. I., TIMMINS, P., AMBROSE, C. V., WARD, M. D., and RIDGWAY, F., 1986, Proliposomes: a novel solution to an old problem. Journal of Pharmaceutical Sciences, 75, 315–329.
- STRAuss, G., and INGENI T 0, E. P., 1980, StabilirAtion of liposome bilayers to freezing and thawing effects of cryoprotective agents and membrane proteins. Cryobiology, 17, 508–515.